All news from Medical Genetics

Health Insurance Sector in India and Ayushman Bharat, Impact Highlighted

With the government's implementation of the Ayushman Bharat-National Health Protection Mission in September 2018, the health insurance sector in India stands to gain like never before. A health policy for the socio-economically underprivileged sections of the country, Ayushman Bharat will likely benefit nearly 500 million Indians or 100 million families, by providing them with health insurance of up to Rs 5 lakh per year. Although the underlying framework for the scheme's pricing and delivery is still under consideration, the central and state governments will finance it.

Research on Tobacco-related Health Risks, USC remains at the Forefront

A new, $ 17.8 million grant will ensure USC remains at the forefront of research to protect people from tobacco-related health risks. The money will be used to promote biomedical and behavioral research to build the scientific underpinning for regulation of tobacco products . USC is part of a national, federally funded program to assess and prevent harm from tobacco products.

Bioresorbable Optical Probe for Brain Implant Developed

A University of Texas at Arlington electrical engineer is working in collaboration with a pioneer in the field to develop an implantable optical probe that can be inserted in the brain and used to monitor brain function after traumatic injuries or surgeries, then be absorbed by the body. If successful, the device would increase patient comfort during recovery and lessen the risks of complications from surgery to remove monitoring devices.

Research in the Field of Commensal Microbiota, Study

The winner of the Johanna Duermueller-Bol DBMR Research Award 2018 is Dr. Stephanie Ganal-Vonarburg. As a Senior Scientist, she conducts research in the Gastroenterology / Mucosal Immunology Research Laboratory at Bern University Hospital and at the Department for BioMedical Research at the University of Bern. Ganal-Vonarburg is being awarded for its research in the field of commensal microbiota – the microbes in the intestine.

Measles and Rubella Vaccines: InDevR's New VaxArray to Improve Potency Testing

InDevR announced that it will follow proof of concept development for new VaxArray potency assays for measles (M) and rubella vaccines sponsored by the Bill & Melinda Gates Foundation.

The long-term objective is to create in vitro measles and rubella potency assays in order to deliver high-quality MR vaccines to market faster and with lower production costs. The project will leverage the multiplexed VaxArray platform, which was first developed and validated for more efficient potency testing of influenza vaccines.